39 points

And they made $18 billion last year.

permalink
report
reply
-40 points

Yeah, well, their R&D budget for this medicine cost something crazy like $3.5 trillion dollars, so it makes sense that they have to charge 200x the cost to make it.

permalink
report
parent
reply
23 points

No, it doesn’t.

permalink
report
parent
reply
-25 points

Yes it does

permalink
report
parent
reply
16 points

Source on that?

permalink
report
parent
reply
8 points

He pulled it from his ass. Everyone fed the troll.

permalink
report
parent
reply
-17 points

I’m sitting on it.

permalink
report
parent
reply
8 points

I am willing to bet they took government money to fund this. So I don’t really accept the argument that they need to price it that much to make profits. How much more profits is the only thin remaining to determine and I don’t have a lot of sympathy for sociopaths who claim they need so much.

permalink
report
parent
reply
8 points

Wow, that would make the company bankrupt now. They owe HOW much?!?! Why haven’t they alone tanked the economy? Geez.

permalink
report
parent
reply
-9 points

That’s what I’m saying! How is it they are able to stay afloat???

permalink
report
parent
reply
7 points

Did you just sarcasm all over the place?

permalink
report
parent
reply
4 points

Maaaayyyyybeeee 😉

permalink
report
parent
reply
21 points

I got the flu for free and I’ve lost a good ten pounds this week.

permalink
report
reply
3 points

This is the best summary I could come up with:


Ozempic could be profitably produced for less than $5 a month even as maker Novo Nordisk A/S charges almost $1,000 in the US, according to a study that revives questions about prices for top-selling treatments for diabetes and obesity.

The blockbuster drug could be manufactured for 89 cents to $4.73 for a month’s supply, figures that include a profit margin, researchers at Yale University, King’s College Hospital in London and the nonprofit Doctors Without Borders reported in the journal JAMA Network Open.

The study extends research showing how steep US markups are for GLP-1 drugs like Ozempic and Wegovy and underlines longstanding criticism of prices for diabetes therapies, especially insulin.

By some estimates, however, the reductions made those products more profitable because they eliminated rebates paid to pharmacy benefit managers, the middlemen who negotiate prices for payers and employers.

State health plans and Medicaid offices are seeing growing bills for Ozempic and its sister drug Wegovy, raising questions about whether the increases in cost are sustainable.

In January, North Carolina cut off coverage of anti-obesity medicines for state employees, citing soaring costs and lack of agreement on pricing from drugmakers.


The original article contains 795 words, the summary contains 187 words. Saved 76%. I’m a bot and I’m open source!

permalink
report
reply
-12 points

I mean, with stuff like insulin, or cancer treatment, I’m totally against price gouging, but OZEMPIC? That’s a voluntary weight loss supplement. As far as I’m concerned, they can charge whatever the hell they please. There’s always diet / exercise for free. I say this as someone whose weight has fluctuated quite a bit in my life. Any time I let myself go, I knew exactly what I had to do to fix it. I’m currently bouncing back from a period like that and back to working out 4 or 5 times a week and eating less. Shocker, but I’ve lost weight and feel better. Ozempic is right there with liposuction. U can do it if you want to be lazy, but you gotta pay. I’m ok with that.

permalink
report
reply
1 point

…It’s diabetes medication.

permalink
report
parent
reply

BrainWorms

!brainworms@lemm.ee

Create post

Hey, welcome to BrainWorms.

This is a place where I post interesting things that I find and cant categorize into one of the main subs I follow. Enjoy a front seat as i descend into madness

Community stats

  • 825

    Monthly active users

  • 344

    Posts

  • 663

    Comments

Community moderators